Upside, a housing stability platform partnering with health insurers, announced Thursday that it raised $20 million in Series A funding. The company’s AI-powered platform helps payers and employers ...

When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it.

The Series B round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, ...

ARPA-H portfolio companies in the Innovation Showcase included biosensor and wearable startups to monitor vital signs and to obtain patient data previously only available through blood tests.

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal.

The race to develop new obesity drugs is playing out with measures of how much and how quickly patients shed weight. Raj Kannan, CEO of startup Alveus Therapeutics, sees the field shaping up as a ...

The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care.

Blocking proteins that drive inflammation is a tried and true way of treating immunological disorders, but Lycia Therapeutics contends its approach of eliminating these proteins could be better. The ...

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near ...

Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...